Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 09 source : Www.eagleus.com save search
Licensing Agreement for U.S. Commercial Rights to Landiolol, a Beta-1 Adrenergic Blocker
Published: 2021-09-09 (Crawled : 19:00) - eagleus.com
EGRX | $4.63 3.35% 3.24% 60K
|
Health Technology
|
| O: -0.86%
H: 1.33%
C: 0.38%
license commercialization
Worldwide Licensing Agreement for CAL02 a Phase 2b/3, Novel First-in-Class Antitoxin Agent
Published: 2021-09-09 (Crawled : 19:00) - eagleus.com
EGRX | $4.63 3.35% 3.24% 60K
|
Health Technology
|
| O: -0.86%
H: 1.33%
C: 0.38%
phase 2 phase 2b license
Eagle Pharmaceuticals Wins Vasopressin Patent Trial
Published: 2021-09-09 (Crawled : 19:00) - eagleus.com
EGRX | $4.63 3.35% 3.24% 60K
|
Health Technology
|
| O: -0.86%
H: 1.33%
C: 0.38%
patent trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.